Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Equity (2020 - 2025)

Historic Return on Equity for AVITA Medical (RCEL) over the last 6 years, with Q4 2025 value amounting to 4.17%.

  • AVITA Medical's Return on Equity rose 115500.0% to 4.17% in Q4 2025 from the same period last year, while for Dec 2025 it was 4.17%, marking a year-over-year increase of 115500.0%. This contributed to the annual value of 7.99% for FY2025, which is 103000.0% up from last year.
  • Latest data reveals that AVITA Medical reported Return on Equity of 4.17% as of Q4 2025, which was up 115500.0% from 4.95% recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Return on Equity ranged from a high of 1581.61% in Q1 2025 and a low of 7.38% during Q4 2024
  • Its 5-year average for Return on Equity is 78.91%, with a median of 0.27% in 2022.
  • Per our database at Business Quant, AVITA Medical's Return on Equity tumbled by -65800bps in 2024 and then skyrocketed by 15829400bps in 2025.
  • AVITA Medical's Return on Equity (Quarter) stood at 0.15% in 2021, then tumbled by -101bps to 0.31% in 2022, then crashed by -157bps to 0.8% in 2023, then crashed by -824bps to 7.38% in 2024, then soared by 156bps to 4.17% in 2025.
  • Its Return on Equity stands at 4.17% for Q4 2025, versus 4.95% for Q3 2025 and 5.89% for Q2 2025.